Kidney xenotransplantation as an investigational rescue strategy: a clinical perspective on high-KDPI kidney allograft as a comparator

Kidney transplantation is the gold standard treatment for end-stage kidney disease. Despite increasing transplant case volume in recent years, its access is limited due to a donor organ shortage, resulting in significant waitlist mortality. Xenotransplantation has the potential to address this unmet need and has made significant progress from early, largely unsuccessful nonhuman-primate experiments in the 1960s to early clinical application in the 2020s: genetically modified pig kidneys have now provided dialysis-independent function in a few living human recipients, sustained for months in some cases. These clinical experiences, together with preclinical nonhuman-primate data, demonstrate that genetically modified pig kidneys can achieve meaningful short-term renal replacement. However, graft durability remains a challenge partly due to immunologic rejection, complement activation, and infection. Given these limitations, kidney xenotransplantation cannot yet be considered a routine alternative to human kidney transplantation. We argue that, at its current stage, it is most appropriately positioned as an investigational rescue strategy for carefully selected patients who face high mortality risk on dialysis and a low likelihood of timely allotransplantation, and that its clinical value should be benchmarked against the expected longevity of high-Kidney Donor Profile Index allografts rather than judged against optimal human kidneys alone. Continued advances in genetic engineering, immunosuppression, and post-transplant monitoring may allow xenotransplantation to approach outcomes comparable to allotransplantation over time, though whether and when this will occur remains uncertain.

Authors

Institutions

Publication Details

Journal
Frontiers in Transplantation
Published
2026-11-19
DOI
https://doi.org/10.3389/frtra.2026.1987120
Primary Topic
Xenotransplantation and immune response
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Kidney xenotransplantation as an investigational rescue strategy: a clinical perspective on high-KDPI kidney allograft as a comparator

Spencer A. Bonham, Patrícia Viana, Shinichiro Yokota, Paulo Ney Aguiar Martins
Frontiers in Transplantation
Xenotransplantation and immune response
article

Kidney xenotransplantation as an investigational rescue strategy: a clinical perspective on high-KDPI kidney allograft as a comparator

Spencer A. Bonham, Patrícia Viana, Shinichiro Yokota, Paulo Ney Aguiar Martins
article en

Abstract

Kidney transplantation is the gold standard treatment for end-stage kidney disease. Despite increasing transplant case volume in recent years, its access is limited due to a donor organ shortage, resulting in significant waitlist mortality. Xenotransplantation has the potential to address this unmet need and has made significant progress from early, largely unsuccessful nonhuman-primate experiments in the 1960s to early clinical application in the 2020s: genetically modified pig kidneys have now provided dialysis-independent function in a few living human recipients, sustained for months in some cases. These clinical experiences, together with preclinical nonhuman-primate data, demonstrate that genetically modified pig kidneys can achieve meaningful short-term renal replacement. However, graft durability remains a challenge partly due to immunologic rejection, complement activation, and infection. Given these limitations, kidney xenotransplantation cannot yet be considered a routine alternative to human kidney transplantation. We argue that, at its current stage, it is most appropriately positioned as an investigational rescue strategy for carefully selected patients who face high mortality risk on dialysis and a low likelihood of timely allotransplantation, and that its clinical value should be benchmarked against the expected longevity of high-Kidney Donor Profile Index allografts rather than judged against optimal human kidneys alone. Continued advances in genetic engineering, immunosuppression, and post-transplant monitoring may allow xenotransplantation to approach outcomes comparable to allotransplantation over time, though whether and when this will occur remains uncertain.

Frontiers in TransplantationVol. 5
University of Oklahoma (US)
Xenotransplantation and immune response
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon